Ipramidil (C80-1324) is a furazan-based compound with potent coronary vasodilatory activity in isolated heart preparations; it increases coronary flow more effectively than glyceryl trinitrate (GTN) without inducing tachyphylaxis upon repeated or continuous administration; it retains its vasodilatory efficacy under nitrate-tolerant conditions; unlike GTN, it also concentration-independently increases spontaneous heart rate by 10–30 beats per minute and exhibits a weak positive inotropic effect.